Share
Hypofractionation Radiotherapy in Post Mastectomy breast cancer
Peter Rotich
(Author)
·
LAP Lambert Academic Publishing
· Paperback
Hypofractionation Radiotherapy in Post Mastectomy breast cancer - Rotich, Peter
Choose the list to add your product or create one New List
✓ Product added successfully to the Wishlist.
Go to My Wishlists
Origin: U.S.A.
(Import costs included in the price)
It will be shipped from our warehouse between
Monday, July 22 and
Monday, July 29.
You will receive it anywhere in United Kingdom between 1 and 3 business days after shipment.
Synopsis "Hypofractionation Radiotherapy in Post Mastectomy breast cancer"
Radiation-induced toxicity is still the main problem with patients undergoing breast or chest wall radiotherapy. Hypofractionated radiotherapy treatment utilises high dose per fraction compared to conventional, as such, concerns of increased toxicity exists. However, some studies have shown similarity in toxicity outcomes between hypofractionated treatment using 40 - 42.5 Gy in 15 - 16 fractions and conventional fractionation of 50 Gy in 2 Gy fractionation in patients who have undergone either breast conservation surgery or lumpectomy in early breast cancer. More high quality comparative hypofractionated radiotherapy studies on the whole breast and breast conservation surgery caseshave been reported compared to hypofractionated studies in postmastectomy patients requiring chest wall radiotherapy.Though, few large scales randomised controlled studies have been reportedsuchas START B trial which had 133 post-mastectomy patients outof 1079 patients sampled.Thus, this study sought to explore further the toxicity outcomes in hypofractionated treatments in early breast cancer postmastectomy in comparison with conventional fractionation.
- 0% (0)
- 0% (0)
- 0% (0)
- 0% (0)
- 0% (0)
All books in our catalog are Original.
The book is written in English.
The binding of this edition is Paperback.
✓ Producto agregado correctamente al carro, Ir a Pagar.